PROF.DR. AYŞE ÇEFLE
Kişisel Bilgiler
Yabancı dil İngilizce,
Akademik Unvanlar
Prof.Dr., Kocaeli Üniversitesi Tıp Fakültesi İç Hastalıkları AD Romatoloji BD, 1997- Devam ediyor,
Yayınlar
a)“SCI expanded” dergilerde yayımlanan çalışmalar (son 3 yıl):
1- Karadag DT, Sahin T, Tekeoglu S, Işik OO, Yazici A, Eraldemir FC, Cefle A. Evaluation of left and right ventricle by two-dimensional speckle tracking echocardiography in systemic sclerosis patients without overt cardiac disease. Clin Rheumatol 2020;39(1):37-48.
2- Karadag DT, Tekeoglu S, Yazici A, Isik OO, Eraldemir FC, Cefle A. TNF-Related Apoptosis-Inducing Ligand Receptor 1 in Patients With Ankylosing Spondylitis. J Clin Rheumatol 2020;26(6):242-7. doi: 10.1097/RHU.0000000000001050.
3- Aksoy A, Yazici A, Omma A, Cefle A, Onen F, Tasdemir U, Ergun T, Direskeneli H, Alibaz-Oner F. Efficacy of TNFα inhibitors for refractory vascular Behçet's disease: A multicenter observational study of 27 patients and a review of the literature. Int J Rheum Dis 2020;23(2):256-61.
4- Gazel U, Colak S, Sari A, Cansu DÜ, Yazici A, Cefle A, Bes C, Karadag O, Omma A, Direskeneli H, Alibaz-Oner F. Damage assessment in adult IgA vasculitis. Cross-sectional results of a multicentre cohort. Clin Exp Rheumatol. 2020;38 Suppl 124(2):155-60.
5- Mumcu G, Yay M, Aksoy A, Taş MN, Armağan B, Sarı A, Bozca BC, Tekgöz E, Karadağ DT, Badak SÖ, Tecer D, Bes C, Şahin A, Erken E, Cefle A, Çınar M, Yılmaz S, Karaçaylı Ü, Alpsoy E, Şenel S, Yaşar Bilge Ş, Kaşifoğlu T, Karadağ Ö, Aksu K, Keser G, Alibaz-Öner F, İnanç N, Ergun T, Direskeneli H. Predictive factors for work-day loss in Behçet's syndrome: A multi-center study. Int J Rheum Dis. 2020 Feb;23(2):240-6.
6- Kara B, Ekinci Z, Sahin S, Gungor M, Gunes AS, Ozturk K, Adrovic A, Cefle A, Inanç M, Gul A, Kasapcopur O. Monogenic lupus due to spondyloenchondrodysplasia with spastic paraparesis and intracranial calcification: case-based review. Rheumatol Int. 2020;40(11):1903-10.
7- Alibaz-Oner F, Ergelen R, Yıldız Y, Aldag M, Yazici A, Cefle A, Koç E, Artım Esen B, Mumcu G, Ergun T, Direskeneli H. Femoral vein wall thickness measurement: A new diagnostic tool for Behçet's disease. Rheumatology (Oxford). 2020 Aug 5:keaa264. doi: 10.1093/rheumatology/keaa264.
8- Yazici A, Ozdemir Isik O, Temiz Karadag D, Cefle A. Are there any clinical differences between ankylosing spondylitis patients and familial mediterranean fever patients with ankylosing spondylitis? . Int J Clin Pract. 2020 Aug 5:e13645. doi: 10.1111/ijcp.13645.
9- Alibaz-Oner F, Ergelen R, Ergenc I, Seven G, Yazici A, Cefle A, Bes C, Atug, Direskeneli H. Femoral Vein Wall Thickness Measurement May Be a Distinctive Diagnostic Tool to Diferentiate Behçet’s Disease with Intestinal Involvement and Crohn’s Disease. Dig Dis Sc 2020 sep doi. 10.1007/s10620-020-06587-7
10- Eren N, Gungor O, Sarisik FN, Sokmen F, Tutuncu D, Cetin GY, Yazici A, Gökçay Bek S, Altun E, Altunoren O, Cefle A. Renal Tubular Acidosis in Patients with Systemic Lupus Erythematosus. .Kidney Blood Press Res. 2020 Oct 27:1-7. doi: 10.1159/000509841.
11- Mumcu G, Yay M, Karaçaylı Ü, Aksoy A, Taş MN, Armağan B, Sarı A, Bozca BC, Tekgöz E, Temiz Karadağ D, Badak SÖ, Tecer D, Yıldırım A, Bes C, Şahin A, Erken E, Cefle A, Çınar M, Yılmaz S, Alpsoy E, Boyvat A, Şenel S, Bilge ŞY, Kaşifoğlu T, Karadağ Ö, Aksu K, Keser G, Alibaz-Öner F, İnanç N, Ergun T, Direskeneli H. Moderation analysis exploring associations between age and mucocutaneous activity in Behçet's syndrome: A multicenter study from Turkey. .J Dermatol. 2020 Sep 27. doi: 10.1111/1346-8138.15553.
12- Ozkul O, Yazıcı A, Sikar A, Karadag DT, Isık OO, Tekeoglu S, Çefle A. Are There any differencies among psoriasis, psoriatic arthritis and romatoid arthritis in terms of metabolic syndrome and cardiovascular risk factors. Eur J Rheumatol 2019;6(4):174-8.
13- Temiz Karadag D, Sahin T, Tekeoglu S, Ozdemir Isik O, Yazici A, Cefle A. Epicardial adipose tissue thickness in systemic sclerosis patients without overt cardiac disease. Rheumatol Int. 2019;39(7):1191-200.
14- Temiz Karadag D, Karakas F, Tekeoglu S, Yazici A, Isik OO, Cefle A. Validation of Turkish version of the Scleroderma Health Assessment Questionnaire. Clin Rheumatol. 2019;38(7):1917-23.
15- Mumcu G, Karacayli Ü, Yay M, Aksoy A, Taş MN, Armağan B, Sari A, Bozca BC, Tekgöz E, Karadağ DT, Badak SÖ, Tecer D, Bes C, Şahin A, Erken E, Cefle A, Çinar M, Yilmaz S, Alpsoy E, Şenel S, Bilge ŞY, Kaşifoğlu T, Karadağ Ö, Aksu K, Keser G, Alibaz-Öner F, Inanç N, Ergun T, Direskeneli H. Oral ulcer activity assessment with the composite index according to different treatment modalities in Behçet's syndrome: a multicentre study.
Clin Exp Rheumatol. 2019 Nov-Dec;37 Suppl 121(6):98-104. Epub 2019 Dec 9.
16- Ortiz-Fernández L, Carmona FD, López-Mejías R, González-Escribano MF, Lyons PA, Morgan AW, Sawalha AH, Smith KGC, González-Gay MA, Martín J; Spanish GCA Study Group, UK GCA Consortium, Turkish Takayasu Study Group, Vasculitis Clinical Research Consortium, IgAV Study Group, AAV Study group. Cross-phenotype analysis of Immunochip data identifies KDM4C as a relevant locus for the development of systemic vasculitis. Ann Rheum Dis. 2018 Apr;77(4):589-595.
b) Yurt dışı kongre bildirileri ( son 3 yıl):
1- Ö. Özdemir Işik, A. Yazici, A. Cefle. Malignancies in Patients with Primary Sjogren’s Syndrome. Ann Rheum Dis 2020;79(Suppl 1):1518, 2020 EULAR, AB0438.
2- Ö. Özdemir Işik, A. Yazici, A. Cefle. Lung findings in patients with primary Sjogren’s syndrome. Ann Rheum Dis 2020;79(Suppl 1):1518-9, 2020 EULAR, AB0439.
3- Ö. Özdemir Işik, S. İsgören, A. Yazici, A. Cefle. Use of positron emission tomography in rheumatology practise. Ann Rheum Dis 2020;79(Suppl 1):1555-6, 2020 EULAR, AB0517.
4- N. Gokcen, A. Komac, F. Tuncer, A. Yazici, A. Cefle. Sleep Hygiene: Could it be a confounding factor for sleep quality in systemic sclerosis? Ann Rheum Dis 2020;79(Suppl 1):1578, 2020 EULAR, AB0562.
5- D. Temiz Karadağ, A. Yazici, A. Komac, Y. Erez, M. Birlik, A. Akdoğan, A. Sari, B. Farisoğullari, G. Kimyon, D. Arslan, E. Koc, S. S. Koca, A. Karatas, N. Kasifoglu, E. Alpaslan, A. Cefle. Comprehensive analysis of autoantibody profile in a Turkish systemic sclerosis cohort. Ann Rheum Dis 2020;79(Suppl 1):1604-5, 2020 EULAR, AB0618.
6- F. Alibaz-Oner, R. Ergelen, Y. Yildiz, A. Yazici, M. Aldag, A. Cefle, B. Artim-Esen, G. Mumcu, T. Ergun, H. Direskeneli. Assessment of femoral vein wall thickness with with soppler US as a diagnostic tool for Behcet’s disease. Ann Rheum Dis 2020;79(Suppl 1):833-4, 2020 EULAR, FRI0473.
7- A. Yazici, A. Cefle, E. Dalkiliç, G. Can, S. Senel, S. S. Koca, N. Inanc, B. Goker, S. Yilmaz, S. Akar, O. Soysal, Y. Pehlivan, M. A. Ozturk, İ. Sari, H. Direskeneli, F. Onen
Are there any differences between Adult-onset rheumatoid arthritis patients and Late-onset rheumatoid arthritis patients in terms of use of biological drugs and drug retention rate? Results from the TURKBIO registry. Ann Rheum Dis 2020;79(Suppl 1):1000, 2020 EULAR, SAT0128.
8- A. Yazici, E. Dalkiliç, M. Birlik, M. A. Öztürk, S. Akar, B. Goker, Y. Pehlivan, S. Senel, A. Cefle, F. Onen. Use of biological DMARDS in patients with Adult-onset Still’s disease: Results from the TURKBIO registry. Ann Rheum Dis 2020;79(Suppl 1):1229, 2020 EULAR, SAT0544.
9- S. B. Kocaer, T. Yüce İnel, Y. Erez, A. Köken Avşar, S. Uslu, A. Karakas, S. Gulle, G. Can, İ. Sari, M. Birlik, E. Dalkiliç, Y. Pehlivan, S. Akar, A. Cefle, M. A. Öztürk, S. Yolbaş, N. Yilmaz, S. Erten, N. Akkoc, F. Onen. LONG-TERM SURVIVAL OF THE FIRST BIOLOGIC TREATMENT IN PSORIATIC ARTHRITIS AND THE EFFECT OF THE SELECTED TREATMENT ON DRUG SURVIVAL; TURKBIO REGISTRY. Ann Rheum Dis 2020;79(Suppl 1):1165-66, 2020 EULAR, SAT0423.
10- Gökçen N, Kaya H, Tuncer F, Yazici A, Cefle A. Case report: a patient with human immune deficiency virus mimicking systemic lupus erythematosus Lupus Sci Med 2020;7(Suppl 1):A50-A51, P46.
11- Yazici A, Ozdemir Isık O, Karadag Temiz D, Çefle A. Are there any clinical differences between ankylosing spondylitis patients and familial mediterranean fever with ankylosing spondylitis patients? 2019 CORA, Presentation number: 23, Floransa, Italya
12- Temiz Karadag D, Gonul B, Tekeoglu S, Yazici A, Çefle A. Malignancy in patients with Systemic Sclerosis: Single Center Experience. 2019 CORA, Presentation number: 99, Floransa, Italya.
13- Ozdemir Isık O, Yazici A, Çefle A. Primary Sjögren’s Syndrome and Malignancy. 2019 CORA, Presentation number: 103, Floransa, Italya.
14- Ozlem Ozdemir Isık, Senem Tekeoglu, Duygu Temiz Karadag, Ayten Yazici, Ayse Çefle. Single center experience with 402 familial Mediterranean fever patients. 2019 ISSAID, P1016, Cenova, Italya.
15- Ayse Çefle, Fatma Tuncer, Ayten Yazici. Adult onset Still’s disease complicated with haemophagocytic syndrome: succesfull treatment with IVIG and Tocilizumab. 2019 ISSAID, P1104, Cenova, Italya.
16- Ayten Yazici, Ayse Çefle, Sema Kaymaz Tahra, Nilüfer Alpay Kanıtez, Mete Kara, Önay Gerçek, Handan Yarkan-Tuğsal, Fatoş Önen, Servet Akar, Kenan Aksu, Gökhan Keser, Fatma Alibaz-Öner, Haner Direskeneli. The prevalence of non-vascular pulmonary manifestations in patients with Takayasu’ arteritis: a retrospective multi-centered cohort study. Ann Rheum Dis 2019;78(Suppl 2):830, 2019 EULAR, FRI0299, Madrid, Ispanya
17- Sadettin Uslu, Gerçek Can, Ayse Cefle, Sema Yılmaz, Sinem Burcu Kocaer, Tuba Yüce İnel, Semih Gülle, Süleyman Serdar Koca, Servet Yolbaş, Mehmet Akif Öztürk, Soner Senel, Nevsun Inanc, Ediz Dalkılıç, Ozgül Soysal, Abdurrahman Tufan, Servet Akar, Merih Birlik, İsmail Sari, Nurullah Akkoc, Fatos Onen. The efficacy and safety of anti-TNF a treatment in Ankylosing Spondylitis patients with late onset compared to those with adult onset; The data from TURKBIO registry. Ann Rheum Dis 2019;78(Suppl 2):896, 2019 EULAR, FRI0416, Madrit, Ispanya
18- Nilüfer Alpay Kanıtez, Sema Kaymaz Tahra, Ayten Yazici, Ayse Çefle, Mete Kara, Handan Yarkan-Tuğsal, Önay Gerçek, Servet Akar, Fatoş Önen, Kenan Aksu, Gökhan Keser, Cemal Bes, Sevil Kamalı, Fatma Alibaz-Öner, Haner Direskeneli. The effect of metabolic syndrome on cardiovascular disease and cumulative organ damage in Takayasu’s arteritis. Ann Rheum Dis 2019;78(Suppl 2):1749, 2019 EULAR, AB0575, Madrit, Ispanya
19- Ozlem Ozdemir Isık, Ayten Yazici, Ayse Çefle. Gynecological symptoms and sexuality in Sjogren’s syndrome. Ann Rheum Dis 2019;78(Suppl 2):1712, 2019 EULAR, AB0498, Madrit, Ispanya.
20- Fatma Alibaz-Oner, Rabıa Ergelen, Yasin Yıldız, Ayten Yazici, Aydan Mutıs, Zeynep Erturk, Mustafa Aldag, Ayşe Çefle, Bahar Artim-Esen, Gonca Mumcu, Tulın Ergun and Haner Direskeneli. Assessment of Femoral Vein Wall Thickness with Doppler Ultrasound Can Be a Diagnostic Tool for Behcet’s Disease. 2019 ACR/ARHP Annual Meeting, Abstract Number: 949, Atlanta.
21- Nilufer Alpay-Kanitez, Sema Kaymaz-Tahra, Ayten Yazici, Ayse Cefle, Mete Kara, Handan Yarkan-Tugsal, Onay Gercik, Servet Akar, Fatos Onen, Kenan Aksu, Gokhan Keser, Cemal Bes, Sevil Kamalı, Fatma Alibaz-Oner and Haner Direskeneli. Pregnancy Outcome in Patients with Takayasu Arteritis: The Results of Turkish Takayasu Study Group. 2019 ACR/ARHP Annual Meeting, Abstract Number: 751, Atlanta.
22- Aysun Aksoy, Ayten Yazici, Ahmet Omma, Ayşe Cefle, Fatos Onen, Unal Tasdemir, Tulin Ergun, Haner Direskeneli and Fatma Alibaz-Oner. Efficacy of TNF α Inhibitors for Refractory Vascular Behcet’s Disease: A Multicenter Observational Study of 27 Patients. 2019 ACR/ARHP Annual Meeting, Abstract Number: 1691, Atlanta.
23- Omer Karadag, Shunsuke Furuta, Alojzija Hocevar, Ummugulsum Gazel, Andrea Hinojosa-Azaola, Serdal Ugurlu, Seerapani Gopaluni, Ertugrul Cagri Bolek, Berkan Armagan, Fatma Alibaz-Oner, Matija Tomšič, Gizem Ayan, Ayten Yazici, Eduardo Martin-Nares, Susy Marcela Sánchez-Cubías, Mehmet Nedim Tas, Ayşe Cefle, Kenan Aksu, Hajime Kono, Tamihiro Kawakami, Yoshiyuki Abe, Timuçin Kaşifoğlu, Mehmet Engin Tezcan, Onay Gercik, Sadettin Kilickap, Haner Direskeneli, Seza Ozen, Ali İhsan Ertenli and David Jayne. Target Organ Associations in Polyarteritis Nodosa (PAN): Results of a Worldwide Collaboration Study. 2019 ACR/ARHP Annual Meeting, Abstract Number: 1702, Atlanta.
24- Lykke Midtbøll Ørnbjerg, Lennart Jacobsson, Anne Gitte Loft, Florenzo Iannone, Michael J. Nissen, Eirik Kristianslund, Herman Mann, Maria José Santos, Manuel Pombo-Suarez, Kari K. Eklund, Ziga Rotar, Bjorn Gudbjornsson, Mehmet Akif Öztürk, Catalin Codreanu, Marleen van de Sande, Johan Wallman, Ennio Giulio Favalli, Burkhard Moeller, Joe Sexton, Karel Pavelka, Elsa Vieira-Sousa, Carlos Sánchez-Piedra, Nina Trokovic, Matija Tomsic, Thorvardur J Love, Ayşe Cefle, Ruxandra IONESCU, Irene van der Horst-Bruinsma, Gareth Jones, Cecilie Heegaard Brahe, Merete Lund Hetland and Mikkel Østergaard. Patient Reported Outcomes over 2 Years in Psoriatic Arthritis Patients Initiating Treatment with 1st, 2nd or 3rd TNF Inhibitor in Routine Care – Was PRO Remission Achieved? Results from the EuroSpA Collaboration. 2019 ACR/ARHP Annual Meeting, Abstract Number: 423, Atlanta.
25- Sadettin Uslu, Gercek Can , Ayşe Cefle , Sema Yılmaz, Sinem Burcu Kocaer, Tuba Yüce İnel, Semih Gülle, Süleyman Serdar Koca, Servet Yolbaş, Mehmet Akif Öztürk, Soner Senel, Nevsun Inanc, Ediz Dalkılıç, Ozgül Gunduz, Abdurrahman Tufan, Servet Akar, Merih Birlik, Ismail Sari, Nurullah Akkoç and Fatos Onen. The Efficacy and Safety of Anti-TNFα Treatment in Ankylosing Spondylitis Patients with Late Onset Compared to Those with Adult Onset; The Data from TURKBIO Registry. 2019 ACR/ARHP Annual Meeting, Abstract Number: 1529, Atlanta.
26- Karadağ DT, Sahin T, Tekeoglu S, Isik OO, Yazici A, Cefle A. Epicardial adipose tissue thickness in womwn with systemic sclerosis. 5th Systemic Sclerosis World Congress, JSRD 2018; P.126, Bordeaux, France.
27- Karadağ DT, Tekeoglu S, Isik OO, Yazici A, Cefle A. The validation of Cochin hand functional scale questionnaire in Turkish speaking patients with systemic sclerosis. 5th Systemic Sclerosis World Congress, JSRD 2018; P.142, Bordeaux, France.
28- Tekeoglu S, Karadağ DT, Isik OO, Yazici A, Cefle A. Anti-C1q antibodies in Turkish systemic lupus erythematosus patients. 11. European Lupus Meeting. Lupus Sci Med 2018;5(Suppl 1):A42-3, PS2:23, Düsseldorf.
29- Karadağ DT, Yazici A, Cefle A. Tertiary syphilisis in a patient with TRAPS under canakinumab treatment: Case report. XVII Mediterranean Congress of Rheumatology, Clin Exp Rheum 2018;36(Suppl 1):S-57, PT1:015, Genoa, Italy.
30- Koca SS, Öz B, Karataş A, Dalkılıç HE, Can G, Pehlivan Y, Senel S, Yazıcı A, İnanç N, Cefle A, Ertürk Z, Akar S, Yağız B, Göker B, Birlik AM, Önen F. Concomitant use of corticosteroids at the baseline does not affect the drug survival of abatacept in rheumatoid arthritis. EULAR 2818, Ann Rheum Dis 2018;77(Suppl 2):597, FRI0105, Amsterdam.
31- İnanç N, Özen G, Yalçınkaya Y, Dalkılıç HE, Koca SS, Can G, Karataş A, Pehlivan Y, Yazıcı A, Cefle A, Tufan A, Akar S, Senel S, Öz B, Akkoç N, Önen F. Is there any difference in RA patients for methotrexate use vs leflunomide use as a concomitant treatment with biological and targeted synthetic DMARDS in TURKBİO Registry? EULAR 2018, Ann Rheum Dis 2018;77(Suppl 2):611, FRI0134, Amsterdam.
32- Alibaz-Öner F, Balcı MA, Pamuk ON, Zengin O, Tascı M, Dogru A, Bayındır O, Yavuz S, Cefle A,Tezcan ME, Oksuz MF, Kucuksahin O, Omma A, Yasar Bilge S, Kasifoglu T, Ertürk Z, Bes C, Unal AU, Armagan B, Gonullu E, Yazici A, Karadag O, Dalkilic E, Aksu K, Keser G, Direskeneli H. Is relaps rate of giant cell arteritis in real-life experience lower than in the controlled trials? Results os a retrospective, multicentre cohort study. EULAR 2018, Ann Rheum Dis 2018;77(Suppl 2):1118, SAT0526, Amsterdam.
33- Ozdemir Isik O, Gonul B, Erol A, Tekeoğlu S, Temiz Karadag D, Yazıcı A, Cefle A, Tufan A, Akar S, Senel S, Öz B, Akkoç N, Önen F. Demographic and clinical features of familial mediterranean fever patients. EULAR 2018, Ann Rheum Dis 2018;77(Suppl 2):1148, SAT0591, Amsterdam.
34- İnanç N, Ertürk Z, Özen G, Dalkılıç HE, Koca SS, Can G, Karataş A, Pehlivan Y, Yazıcı A, Cefle A, Akar S, Senel S, Öz B, Akkoç N, Direskeneli H. Investigation of poor prognostic factors among rheumatoid arthritis patients in TURKBİO Registry? EULAR 2018, Ann Rheum Dis 2018;77(Suppl 2):1319, AB0278, Amsterdam.
35- Yazıcı A, Omma A, Yilmaz S, Yavuz S, Ayar K, Kasapoglu E, Kisacik B, Cefle A, Erkan D. The clinical and laboratory features of antiphospholipid antibody positive patients with or without systemic lupus erythematosus. EULAR 2018, Ann Rheum Dis 2018;77(Suppl 2):1431, AB0552, Amsterdam.
36- Yazıcı A, Cefle A, Dalkılıç HE, Pehlivan Y, Can G, Goker B, Tufan A, Senel S, Koca SS, Akar S, Akkoç N, Onen F. Use of biological DMARDs in patients with primary vasculitis: Results from TURKBİO Registry. EULAR 2018, Ann Rheum Dis 2018;77(Suppl 2):1470, AB0649, Amsterdam.
37- Alibaz-Öner F, Omma A, Sarı A, Gazel Ü, Üsküdar Cansu D, Yazıcı A, Cefle A, Bes C, Karadag Ö, Direskeneli H. Assessment of damage and prognosis in patients with adult IgA vasculitis: Retrospective multicentered cohort study. EULAR 2018, Ann Rheum Dis 2018;77(Suppl 2):1474, AB0661, Amsterdam.
38- Can G, Dalkılıç HE, Pehlivan Y, Senel S, Akar S, Solmaz D, Koca SS, İnanç N, Atagunduz P, Yazıcı A, Cefle A,Goker B, Zengin B, Uslu S, Akkoç N, Onen F. Comparision of long term anti_TNF survival in patients with ankylosing spondylitis and non-radiographic axial sponyloarthritis; Data from TURKBİO Registry. EULAR 2018, Ann Rheum Dis 2018;77(Suppl 2):1545, AB0835, Amsterdam.
39- Gazel U, Omma A, Sari A, Cansu DU, Yazici A, Cefle A, Bes C, Karadag O, Direskeneli H, Alibaz-Oner F. Assessment of damage and prognosis in patients with adult IgA vasculitis: Retrospective multicentered cohort study. 2018 ACR/ARHP Annual Meeting, Abstract Number: 825, Chicago.
40- Karatas A, Oz B, Dalkilic E, Can G, Pehlivan Y, Senel S, Yazici A, Inanc N, Erturk Z, Cefle A, Akar S, Koca SS, Birlik M, Onen F. Cigarette smoking does not affect treatment response to tofacitinib in rheumatoid arthritis. 2018 ACR/ARHP Annual Meeting, Abstract Number: 1554, Chicago.
41- Babaoglu H, Goker B, Inanc N, Birlik M, , Koca SS, Cefle A, Dalkilic E, Tufan A, Yilmaz S, Senel S, Akar S, Akkoc N, Onen F. Impact of obesity on drug survival of tofacitinib in patients with rheumatoid arthritis: Analysis from the TURKBIO registry. 2018 ACR/ARHP Annual Meeting, Abstract Number: 1547, Chicago.
42- Cefle A, Karadag DT, Ozbilen M, sener SY, Isik OO, Yazici A. Effects of infliximab treatment in term of metabolic parameters and insulin resistance in ankylosing spondylitis patients. Abstract number: 042, 2017 International Congress on Controversies in Rheumatology&Autoimmunity (CORA), Bologna, Italy.
43- Karadag DT, Catan FT, Isik OO, Tekeoglu S, Yazici A, Cefle A. Clinical correlation of CENP-B antibodies in systemic sclerosis patients. Abstract number: 127, 2017 International Congress on Controversies in Rheumatology&Autoimmunity (CORA), Bologna, Italy.
44- Isık ÖÖ, Karadağ DT, Tekeoğlu S, Yazıcı A, Çefle A. A case of hyperimmunglobulin D syndrome treated succesfully with canakinumab. 9th International Congress of Familial Mediterranean Fever and Systemic Auto Inflammmatory Diseases, PP-183, 2017, Northern Cyprus.
45- Yazıcı A, Karadağ DT, Isık ÖÖ, Tekeoğlu S, Çefle A. Use of canakinumab in patient with tumor necrosis factor receptor-associated periodic syndrome (TRAPS): A case report. 9th International Congress of Familial Mediterranean Fever and Systemic Auto Inflammmatory Diseases, PP-183, 2017, Northern Cyprus.
46- Tekeoglu S, Karadag DT, Isik OO, Yazici A, Cefle A. Single centrecenter experience with 150 systemic lupus erythematosus patients. Lupus 2017;4(suppl 1):A95. 12th International Congress on SLE & 7th Asian Congress on Autoimmunity 2017, Abstract Number: 204, Melbourne, Australia.
47- Karadağ DT, Karakas F, Tekeoglu S, Isik OO, Yazici A, Cefle A. The validation of the Scleroderma Health Assessment Questionnaire in Turkish speaking patients with systemic sclerosis. Ann Rheum Dis 2017;76(suppl 2):634. EULAR 2017, FRI0386, Madrid, Spain.
48- Tekeoglu S, Karadag DT, Isik OO, Yazici A, Cefle A. Single center experience with 300 systemic lupus erythematosus patients. Ann Rheum Dis 2017;76(suppl 2):634. EULAR 2017, FRI0296, Madrid, Spain.
49- Akyol L, Toz B, Bayindir O, Zengin O, Cansu DU, Yigit M, Çetin Yildirim G, Omma A, Erden A, Kucuksahin O, Altuner MS, Çorba BS, Unal AU, Küçük H, Küçük A, Balkarlı A, Gonullu E, Tufan AN, Bakırcı Üreyen S, Yılmaz Öner S, Kobak S, Yazici A, Ozgen M, Sahin A, Koca SS, Erer B, Gül A, Aksu K, Keser G, Onat AM, Kisacik B, Kasifoglu T, Cefle A, Kalyoncu U, Sayarlioglu M. Budd-Chiari Syndrome in Behçet’s Disease: A Retrospective Multicenter Study. Ann Rheum Dis 2017;76(suppl 2):634. EULAR 2017, THU0329, Madrid, Spain.
50- S. Akar, M. Cinar, G. Sargin, O. Karadag, G. Kinikli, M. Ozmen, O. Gercik, U. Kalyoncu, S. Yilmaz, T. Senturk, G. Keser, G. Hatemi, F. Yargucu, Y. Ozguler, A. Cefle, D. Kozaci, D. Solmaz, B. Kisacik. Is there any role of immunogenicity on the response to the anti-tumor necrosis factor alpha therapy in patients with ankylosing spondilitis: The first results of a prospective cohort study. Ann Rheum Dis 2017;76(suppl 2). EULAR 2017, THU0389, Madrid, Spain.
51- Inanc N, Ozen G, Yalçınkayan Y, Dalkilic E, Koca SS, Can G, Karatas A, Pehlivan Y, Yazici A, Cefle A, Tufan A, Akar S, Senel S, Oz B, Akkoc N and Onen F. Is There Any Difference in RA Patients for Methotrexate Use Vs. Leflunomide Use As a Concomitant Treatment with Biological and Targeted Synthetic Dmards in Turkbio Registry? 2017 ACR/ARHP Annual Meeting, Abstract Number: 542, San Diego.
52- Inanc N, Erturk Z, Ozen G, Dalkilic E, Koca SS, Can G, Karatas A, Pehlivan Y, Yazici A, Cefle A, Akar S, Senel S, Oz B, Akkoc N, Direskeneli H and Onen F. Investigation of Poor Prognostic Factors Among Rheumatoid Arthritis Patients in Turkbio Registry2017 ACR/ARHP Annual Meeting, Abstract Number: 1455, San Diego.
53- Koca SS, Karatas A, Oz B, Dalkilic E, Can G, Pehlivan Y, Yazici A, Inanc N, Cefle A, Erturk Z, Akar S, Senel S, Birlik M, Akkoc N and Onen F. Body Mass Index Does Not Affect Response to Rituximab in Patients with Rheumatoid Arthritis: Results from Turkbio Registry2017 ACR/ARHP Annual Meeting Abstract Number: 1472, San Diego.
54- Can G, Dalkılıç E, Pehlivan Y, Senel S, Akar S, Solmaz D, Koca SS, Inanc N, Atagunduz P, Yazıcı A, Cefle A, Goker B, Zengin B, Uslu S, Akkoç N and Onen F. Comparison of Long Term Anti-Tnf Survival in Patients with Ankylosing Spondylitis and Non-Radiographic Axial Spondyloarthritis; Data from Turkbio Registry. 2017 ACR/ARHP Annual Meeting Abstract Number: 1534, San Diego.